| 摘要 |
<p>The invention regards a method for screening compounds that interact with hFSHR (poly)peptides and therapeutic agents thereof, for use in the treatment of conditions affecting human central and peripheral nervous system, kidney, thymus, bronchus, trachea, aorta and prostate.</p> |
